Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.

Rezai T, Yu B, Millhauser GL, Jacobson MP, Lokey RS.

J Am Chem Soc. 2006 Mar 1;128(8):2510-1.

PMID:
16492015
2.

Conformations of heterochiral and homochiral proline-pseudoproline segments in peptides: context dependent cis-trans peptide bond isomerization.

Kantharaju, Raghothama S, Raghavender US, Aravinda S, Shamala N, Balaram P.

Biopolymers. 2009;92(5):405-16. doi: 10.1002/bip.21207.

PMID:
19373926
4.
5.

Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3.

Malicka J, Groth M, Czaplewski C, Wiczk W, Liwo A.

Biopolymers. 2002 Apr 5;63(4):217-31.

PMID:
11807749
6.

Conformations and conformational interconversions of diastereomeric cyclic tetraprolines.

Link U, Mästle W, Rothe M.

Int J Pept Protein Res. 1993 Nov;42(5):475-83.

PMID:
8106200
7.

Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.

Liederer BM, Fuchs T, Vander Velde D, Siahaan TJ, Borchardt RT.

J Med Chem. 2006 Feb 23;49(4):1261-70.

PMID:
16480263
8.

NMR and X-ray crystallographic studies on cyclic tetrapeptide, cyclo (D-Phe-Pro-Sar-Gly).

Jois DS, Suresh S, Vijayan M, Easwaran KR.

Int J Pept Protein Res. 1996 Jul;48(1):12-20.

PMID:
8844259
9.

The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides.

Gudmundsson OS, Jois SD, Vander Velde DG, Siahaan TJ, Wang B, Borchardt RT.

J Pept Res. 1999 Apr;53(4):383-92.

PMID:
10406216
10.

Conformation and calcium-binding properties of a bicyclic nonapeptide.

Oliva R, Falcigno L, D'Auria G, Zanotti G, Paolillo L.

Biopolymers. 2000-2001;56(1):27-36.

PMID:
11582575
11.

Molecular structures of two crystalline forms of the cyclic heptapeptide antibiotic ternatin, cyclo[-beta-OH-D-Leu-D-Ile-(NMe)Ala-(NMe)Leu-Leu-(NMe)Ala-D-(NMe)Ala-].

Miller R, Galitsky NM, Duax WL, Langs DA, Pletnev VZ, Ivanov VT.

Int J Pept Protein Res. 1993 Dec;42(6):539-49.

PMID:
8307686
12.
13.

Design of a peptide hairpin containing a central three-residue loop.

Rai R, Raghothama S, Balaram P.

J Am Chem Soc. 2006 Mar 1;128(8):2675-81.

PMID:
16492054
14.

The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability.

Gudmundsson OS, Vander Velde DG, Jois SD, Bak A, Siahaan TJ, Borchardt RT.

J Pept Res. 1999 Apr;53(4):403-13.

PMID:
10406218
16.
17.

Unexpectedly fast cis/trans isomerization of Xaa-Pro peptide bonds in disulfide-constrained cyclic peptides.

Shi T, Spain SM, Rabenstein DL.

J Am Chem Soc. 2004 Jan 28;126(3):790-6.

PMID:
14733553
18.

The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.

Heller M, Sukopp M, Tsomaia N, John M, Mierke DF, Reif B, Kessler H.

J Am Chem Soc. 2006 Oct 25;128(42):13806-14.

PMID:
17044709
19.

Enhanced stability of cis Pro-Pro peptide bond in Pro-Pro-Phe sequence motif.

Dasgupta B, Chakrabarti P, Basu G.

FEBS Lett. 2007 Sep 18;581(23):4529-32. Epub 2007 Aug 27.

Supplemental Content

Support Center